Please use a minimum of three unique search wordsOur search is configured to only display links relevant to answer your question. For the best results please use specific and relevant keywords that accurately reflect the information you are seeking.Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Strattera ® (atomoxetine)
Strattera® oral solution Administration Through a NG Tube
The administration of atomoxetine through a nasogastric (NG) tube has not been studied.
The administration of atomoxetine through a nasogastric tube has not been studied, and no data are available regarding the safety of efficacy of this method of administration.
For approved posology and method of administration please refer to summary of product characteristics.1
Date of Last Review: June 30, 2021
Contact Lilly
Call or Email us
If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com
Available Mon - Fri, 10am - 4pm, excluding Bank Holidays